EG.

Remote executive assignments

Remote Executive Sprints

Short senior-level support for decisions that cannot wait. The format is designed for owners, investors, boards, M&A advisors and international partners in pharmaceutical and industrial environments.

The work is designed to produce a decision, a risk map, a board-ready memo or an actionable operating plan — not a long presentation without an owner.
Request a confidential briefing ↗

Remote executive assignments

Four fixed formats

01from €750

1-day Executive Review

For
A critical decision, proposal, supplier, investment or operating issue.
Deliverable
90-minute executive session plus a concise written decision memo with key risks, questions and recommendation.
Best for
CEOs, owners, investors and advisors who need an experienced second opinion quickly.
02€2,000–3,000

2-day Market-Entry Assessment

For
A pharmaceutical or regulated product entering a new market.
Deliverable
Go/no-go view, partner model, regulatory and operational blockers, CMO/API considerations and a 90-day action map.
Best for
Pharma companies, investors and international business-development teams.
03€5,000–8,000

5-day Operational Diagnostic

For
A company facing margin pressure, supply risk, unclear accountability or operational underperformance.
Deliverable
Remote interviews and document review, risk heatmap, priority actions, quick wins and management agenda.
Best for
Owners, CEOs and investors in pharma and regulated manufacturing.
04€10,000–15,000

10-day M&A or Investment Workstream

For
Operational due diligence, post-merger planning, localization or an industrial investment case.
Deliverable
Operating assessment, value-creation opportunities, integration or execution roadmap and board-ready presentation.
Best for
Private equity, family offices, transaction advisors and industrial owners.

How the work is delivered

How the work is delivered

25+ years in pharma and industry. CEO of Infamed Group (2023–2024), Managing Director of Megainpharm GmbH (2010–2025): group revenue above €120M in 2024 and 300+ manufacturing staff. Expertise in international operations, M&A, law and intellectual property.

  • 01

    Secure document exchange before the start

  • 02

    Video interviews and working sessions

  • 03

    Structured written output

  • 04

    Before starting, we agree the document scope, meetings, deliverable and calendar timeline

  • 05

    No site visit required for the initial assessment

Core expertise

Pharmaceutical manufacturingPharma operationsCEO / COOProcurementSupplier riskAPICMO / CDMOMarket entryLocalizationM&AOperational due diligencePost-merger integrationInvestment projectsInternational business

Confidentiality

Assignments are scoped around public, client-owned or properly authorized materials. Confidential information from former companies, non-public transaction data and commercial terms are not disclosed.

Remote executive assignments

Need a fast senior view?

I am available for focused remote assignments of 1–10 working days in English, German and Russian.

Emailevgorokhov@gmail.com ↗LinkedInEvgeny Gorokhov ↗